P38 Non-invasive assessment of metformin induced changes in cardiac and hepatic redox state using hyperpolarized [1–13C] pyruvate. (26th October 2016)

• Record Type: Journal Article
• Authors: Lewis, Andrew JM; Miller, Jack; McCallum, Chloe; Rider, Oliver; Neubauer, Stefan; Heather, Lisa; Tyler, Damian J
• Is Part Of: Heart. Volume 102(2016)Supplement 8
• Page Start: A14
• Page End: A14
• Publication Date: 2016-10-26
• Subjects: Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2016-310696.42
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Background and methods: Metformin's mechanism of action is controversial though may involve suppression of hepatic gluconeogenesis through perturbation of cellular redox state. Hyperpolarized magnetic resonance with [1-13C] pyruvate exploits huge increases in tracer signal to non-invasively assess both the redox coupled lactate dehydrogenase reaction and also pyruvate dehydrogenase activity. We performed hyperpolarized [1-13C] pyruvate magnetic resonance spectroscopic and imaging assessments of heart and liver metabolism in Wistar rats following either a single infusion of metformin or longer term oral treatment. Results: Metformin infusion increased both cardiac and hepatic hyperpolarized [1-13C] lactate:[1-13C] pyruvate ratio (0.22 ± 0.04 versus 0.11 ± 0.01, P = 0.004 and 0.39 ± 0.04 versus 0.30 ± 0.02, P = 0.04 respectively) without changing pyruvate dehydrogenase flux. Metformin also increased both the cardiac and hepatic [lactate]:[pyruvate] ratio, a surrogate of cytosolic redox state (50 ± 8 versus 25 ± 7, P = 0.02 and 72 ± 12 versus 16 ± 8, P = 0.002 respectively). Longer term Metformin treatment for 4 weeks also increased the cardiac and hepatic hyperpolarized [1-13C] lactate:[1-13C] pyruvate ratio (0.27 ± 0.06 versus 0.10 ± 0.01, P = 0.005 and 0.87 ± 0.2 versus 0.36 ± 0.04, P = 0.003 respectively) without significantly changing pyruvate dehydrogenase flux and also increased the cardiac and hepatic [lactate]:[pyruvate] ratio (46 ± 6 versus 30 ± 6, P = 0.04 and 60 ± 9 versus 27 ± 3, P = 0.002 respectively). Conclusions: Both acute and chronic metformin treatment significantly increased both the cardiac and hepatic hyperpolarized [1-13C] lactate:[1-13C] pyruvate ratio, reflecting an increase in cytosolic redox state. These findings 1) identify a novel cardiac effect of metformin, 2) demonstrate the sensitivity of hyperpolarized [1-13C] pyruvate to metformin induced changes in redox biology and 3) have implications for the design of upcoming human studies using hyperpolarized MR to study cardiac metabolism in diabetes.